Needham: Maintaining the Azenta (AZTA.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $75.00 to $75.00.
Zhitong FinanceApr 9 07:40
Azenta Analyst Ratings
BenzingaApr 9 07:35
Optimistic Financial Future and Strategic Growth: A Buy Rating for Azenta
TipRanksApr 9 04:05
Analysts Conflicted on These Healthcare Names: Icon (ICLR), Schrodinger (SDGR) and Azenta (AZTA)
TipRanksApr 4 20:20
Azenta Analyst Ratings
BenzingaApr 4 19:09
Buy Rating Affirmed for Azenta: A Promising Future Backed by Strategic Growth Plans
TipRanksMar 28 17:35
Azenta Analyst Ratings
BenzingaMar 28 17:21
Azenta Analyst Ratings
BenzingaMar 15 01:20
Buy Rating Affirmed: Azenta's Strong Financial Outlook and Strategic Growth Trajectory
TipRanksMar 7 18:25
Azenta Analyst Ratings
BenzingaMar 7 18:09
Azenta Analyst Ratings
BenzingaFeb 9 01:39
Analysts Offer Insights on Healthcare Companies: Azenta (AZTA), Neurocrine (NBIX) and McKesson (MCK)
TipRanksFeb 8 18:30
Azenta Analyst Ratings
BenzingaFeb 8 18:12
Strong Buy Rating for Azenta, Inc. Amid Growth and Strategic Initiatives
TipRanksFeb 8 12:15
Azenta Analyst Ratings
BenzingaFeb 2 00:15
Optimistic Financial Outlook for Azenta: A Strong Buy Rating With Increased Target Price
TipRanksJan 23 02:18
Needham Maintains Buy on Azenta, Raises Price Target to $76
BenzingaJan 19 02:44
Azenta Analyst Ratings
BenzingaJan 19 02:43
Needham Reiterates Buy on Azenta, Maintains $68 Price Target
BenzingaNov 14, 2023 19:21
Azenta Analyst Ratings
BenzingaNov 14, 2023 19:20
No Data
No Data